Abstract:BACKGROUND:Clonorchis sinensis, Opisthorchis viverrini, and Opisthorchis felineus are the three most important human liver fluke species in the Opisthorchiidae family, infecting approximately 25 million people worldwide. Drug treatment is needed to control morbidity and is also useful in lowering transmission. Several drugs used in various regimens are available to treat these infections, but their comparative efficacy is uncertain. We aimed to compare the efficacy in terms of cure rate and egg reduction rate of currently registered drugs against human liver fluke infection.METHODS:We conducted a systematic review using readily available electronic databases (MEDLINE, Embase, Cochrane Central Register of Controlled Trials, KoreaMed, China National Knowledge Infrastructure, and Wanfang Data) without language restrictions from inception until June 29, 2021. Clinical trials with pairwise comparison of drugs (praziquantel, albendazole, mebendazole, tribendimidine, or combinations of these drugs) against C sinensis, O viverrini, and O felineus were eligible, including trials comparing these drugs or their combinations with placebo. We compared efficacy in terms of cure rate by network meta-analysis. We conducted mixed binomial regression analyses for each species to derive predicted median cure rates for each drug regimen. The models included treatment and infection intensity as fixed factors, year of publication as covariate, and random effects of the different studies assumed to be normally distributed. We also assessed the quality of the included studies. This study was registered with PROSPERO (CRD42018109232).FINDINGS:Overall, 26 trials from 25 studies were included, of which 18 involved C sinensis, seven studied O viverrini, and one focused on O felineus. These trials included a total of 3340 participants. The two long-term treatment courses against C sinensis infection using 400 mg of albendazole (400 mg twice a day for 5 days and 400 mg twice a day for 7 days) resulted in cure rates of 100%, while two other multiple-dose regimens of albendazole resulted in high predicted cure rates: 300 mg twice a day for 5 days (93·9% [95% CI 49·6-99·6]) and 400 mg twice a day for 3 days (91·0% [50·9-99·0]). The WHO-recommended praziquantel regimen (25 mg/kg three times a day for 2 days) also showed a high predicted cure rate (98·5% [85·4-99·9]) in C sinensis infection, and predicted cure rates were above 90% for several other multiple-dose praziquantel regimens, including 20 mg/kg three times a day for 3 days (97·6% [74·7-99·8]), 14 mg/kg three times a day for 5 days (93·9% [44·8-99·7]), and 20 mg/kg twice a day for 3 days (91·0% [50·9-99·0]). In O viverrini infection, the regimen of 50 mg/kg and 25 mg/kg of praziquantel given in a single day showed the highest predicted cure rate (93·8% [85·7-97·5]), while a single dose of 50 mg/kg praziquantel also resulted in a high predicted cure rate (92·1% [64·9-98·6]). The single dose of 400 mg tribendimidine showed a high predicted cure rate of 89·8% (77·5-95·8). A low quality of evidence was demonstrated in most studies, especially those published before 2000. Selection bias due to poor random sequence generation and allocation concealment was high, and performance and detection biases were frequently unreported.INTERPRETATION:Praziquantel shows high efficacy against clonorchiasis and opisthorchiasis. Tribendimidine might serve as a treatment alternative and warrants further investigation. Although albendazole is efficacious when long treatment schedules (5 days or 7 days) are applied, limited size of studies and high risk of bias affect the interpretation of results. More high-quality studies are needed to promote the establishment of treatment guidelines for human liver fluke infection.FUNDING:Fourth Round of Three-Year Public Health Action Plan (2015-2017; Shanghai, China) and Swiss National Science Foundation.

Accuracy of the Kato-Katz Method and Formalin-Ether Concentration Technique for the Diagnosis of Clonorchis Sinensis, and Implication for Assessing Drug Efficacy

Improving diagnostic performance of the Kato-Katz method for Clonorchis sinensis infection through multiple samples

A point-of-care testing assay for clonorchiasis using a EuNPs-CsTR1 fluorescent probe-based immunoassay

Performance evaluation of existing immunoassays for Clonorchis sinensis infection in China

Rapid Screening of Clonorchis Sinensis Infection: Performance of a Method Based on Raw-Freshwater Fish-Eating Practice.

Field Evaluation of an Immunochromatographic Test for Diagnosis of Cystic and Alveolar Echinococcosis.

Efficacy of Drugs Against Clonorchiasis and Opisthorchiasis: a Systematic Review and Network Meta-Analysis

Epidemiology and determinants of Clonorchis sinensis infection: A community-based study in southeastern China

Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control

Epidemiology and determinants of<i> Clonorchis</i><i> sinensis</i> infection: A community-based study in southeastern China

Efficacy assessment of miltefosine and curcumin against Clonorchis sinensis infection

A Duplex PCR for the Simultaneous Detection of Fasciola Hepatica and Clonorchis Sinensis.

Efficacy and safety of tribendimidine against Clonorchis sinensis.

Efficacy and Safety of Praziquantel, Tribendimidine and Mebendazole in Patients Infected with Clonorchis Sinensis

Assessment of control strategies against Clonorchis sinensis infection based on a multi-group dynamic transmission model

Combinatorial Treatment with Praziquantel and Curcumin Reduces Clonorchis sinensis Parasite Burden and Clonorchiasis-Associated Pathologies in Rats

High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China

[Analysis of Current Drug Treatment Against Clonorchiasis in China].

Multi-omics approaches reveal the molecular mechanisms underlying the interaction between Clonorchis sinensis and mouse liver

[Value of discriminant analysis for screening of clonorchiasis sinensis]

Severe Hepatobiliary Morbidity is Associated with Clonorchis Sinensis Infection: the Evidence from a Cross-Sectional Community Study.